Hyperfine (HYPR) EBT Margin Growth (1y) (2022 - 2026)
Hyperfine (HYPR) EBT Margin Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -719.00 |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 687.00 |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 458.00 |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 88.00 |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 374.00 |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 343.00 |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 84.00 |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | -126.00 |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 165.00 |
| 10 | Hyperfine | 89.83 Mn | 45.06 Mn | 1.98 Mn | 10,401.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10,401.00 |
| Mar 31, 2026 | 21,978.00 |
| Dec 31, 2025 | 33,596.00 |
| Sep 30, 2025 | -3,715.00 |
| Jun 30, 2025 | -6,247.00 |
| Mar 31, 2025 | -14,183.00 |
| Dec 31, 2024 | -4,989.00 |
| Sep 30, 2024 | 17,823.00 |
| Jun 30, 2024 | 3,491.00 |
| Mar 31, 2024 | 16,260.00 |
| Dec 31, 2023 | 51,930.00 |
| Sep 30, 2023 | 9,927.00 |
| Jun 30, 2023 | 119,609.00 |
| Mar 31, 2023 | 111,407.00 |
| Dec 31, 2022 | 506,573.00 |
| Sep 30, 2022 | 385,738.00 |
| Jun 30, 2022 | 256,193.00 |
| Mar 31, 2022 | 77,914.00 |